Marquez L A, Dunford H B
Department of Chemistry, University of Alberta, Edmonton, Canada.
J Biol Chem. 1994 Mar 18;269(11):7950-6.
The chlorination of taurine by the myeloperoxidase-H2O2-Cl- system was investigated under steady state conditions. By systematically varying the pH and the concentrations of H2O2,Cl-, and taurine such that chloride inhibition and the unwanted formation of inactive compound II intermediate are minimized, rate data were found to fit a mechanism involving an enzyme-bound chlorinating intermediate. The mechanism we propose is as follows. [formula: see text] The kinetic parameters determined at pH 4.7 are: k1 = (3.3 +/- 0.2) x 10(7) M-1 S-1, k2 = (2.8 +/- 1.2) x 10(6) M-1 S-1, and k3 = (4.4 +/- 0.2) x 10(5) M-1 S-1. The rate constant for compound I formation (k1) is of the same order of magnitude as the value (1.8 x 10(7) M-1 S-1) obtained using transient state techniques in a previous study by our group. The value of k3 is 2 orders of magnitude greater than the non-enzymatic reaction between HOCl and taurine at the same pH. The results of this study indicate that the chlorination reaction mediated by the myeloperoxidase system in vivo may involve an enzyme intermediate species rather than free HOCl. Not only does this mechanism offer the advantage of substrate specificity but also of speed compared to the non-enzymatic reaction. This mechanism can also explain how the indiscriminate oxidation reactions by HOCl are prevented in the leukocyte. The fast formation of taurine monochloramine, a relatively non-toxic and stable compound compared to HOCl, is consistent with the proposed role of taurine in the neutrophil, that of protecting certain targets including myeloperoxidase from the attack by potent chlorinated oxidants.
在稳态条件下研究了髓过氧化物酶-H₂O₂-Cl⁻系统对牛磺酸的氯化作用。通过系统地改变pH值以及H₂O₂、Cl⁻和牛磺酸的浓度,使氯离子抑制作用和无活性化合物II中间体的不必要形成最小化,发现速率数据符合涉及酶结合氯化中间体的机制。我们提出的机制如下。[公式:见原文]在pH 4.7时测定的动力学参数为:k₁ = (3.3 ± 0.2) × 10⁷ M⁻¹ s⁻¹,k₂ = (2.8 ± 1.2) × 10⁶ M⁻¹ s⁻¹,k₃ = (4.4 ± 0.2) × 10⁵ M⁻¹ s⁻¹。化合物I形成的速率常数(k₁)与我们小组先前研究中使用瞬态技术获得的值(1.8 × 10⁷ M⁻¹ s⁻¹)处于同一数量级。k₃的值比相同pH下HOCl与牛磺酸之间的非酶反应大2个数量级。本研究结果表明,体内髓过氧化物酶系统介导的氯化反应可能涉及酶中间物种而非游离的HOCl。与非酶反应相比,该机制不仅具有底物特异性优势,还具有速度优势。该机制还可以解释白细胞中如何防止HOCl的无差别氧化反应。与HOCl相比,牛磺酸一氯胺这种相对无毒且稳定的化合物的快速形成,与牛磺酸在中性粒细胞中的假定作用一致,即保护包括髓过氧化物酶在内的某些靶点免受强效氯化氧化剂的攻击。